| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |